More than 200 Biomaterials Developed and Manufactured
Outsourcing solutions to scale up manufacturing processes in different expression systems and a broad range of systems for analytical characterization to obtain highly purified biomaterials in a timely and cost-effective manner.
YOUR EXPERT ON BIOMATERIALS
Customized development and manufacturing of biomaterials for diagnostic use
The IVD industry benefits from our experience in designing, developing and manufacturing biomaterials that can be delivered in large batches with proven results in diagnostic kits.
Manufacturers can implement expression, purification and analytical characterization procedures in our facilities to obtain antigens and antibodies for their assays in a timely manner.
BROAD RANGE OF BIOMATERIALS AVAILABLE IN OUR CATALOG
Antigens and antibodies
Antibodies and antigens with proven performance in different commercialized immunoassays around the globe.
Biomaterials for immunoassays
Biomaterials Technical Notes
Check our technical notes to see how our biomaterials work in immunoassays
Technical note on CLIA prototype for quantitative detection of Placental Growth factor in human serum
Technical note on CLIA prototype for quantitative detection of sFlt-1 in human serum
Technical note on recombinant T Pallidum antigens performance on CLIA for qualitative detection of antibodies to T pallium
Technical note on recombinant Hepatitis B core antigen performance on CLIA for qualitative detection of antibodies to Hepatitis B core ag
Technical note on Hepatitis B surface antigen performance on CLIA for qualitative detection of antibodies to HBs
Technical note on Hepatitis B surface antigen antibodies performance on CLIA for qualitative determination of Hepatitis B surface antigen
Technical note on recombinant HCV antigens performance on CLIA for qualitative detection of antibodies to Hepatitis C Virus
Technical note on CLIA prototype for quantitative detection of antibodies (IgG) to Hepatitis E Virus in human serum
Technical note on Rubella Antigen performance on CLIA for qualitative detection of antibodies (IgG) to Rubella virus
Technical note on Rubella Antigen performance on CLIA for qualitative detection of antibodies (IgM) to Rubella Virus
Technical note on recombinant gG1 antigen performance on CLIA for qualitative detection of antibodies (IgG) to HSV-1
Technical note on recombinant gG2 antigen performance on CLIA for qualitative detection of antibodies (IgG) to HSV-2
Please contact us directly via telephone or with the following form.
Tel. +34 93 860 90 00